abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Common Stock
$304.08K
Quarterly · Period ending: · USD
HQL Common Stock
Latest reported$304.08Kperiod ending
Latest reported$304.08Kperiod ending
HQL Quarterly Common Stock ($80.50M → $304.08K)
Quarterly common stock
High-resolution chart · PNG
HQL common stock history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Common Stock (USD) |
|---|---|
| 304,080 | |
| 295,987 | |
| 288,724 | |
| 280,614 | |
| 273,505 | |
| 267,912 | |
| 262,120 | |
| 256,796 | |
| 251,440 | |
| 246,684 | |
| 242,794 | |
| 238,832 | |
| 349,632,625 | |
| 345,293,719 | |
| 339,380,742 | |
| 333,784,022 | |
| 325,961,910 | |
| 317,621,000 | |
| 309,002,000 | |
| 301,308,000 | |
| 290,443,000 | |
| 281,457,000 | |
| 271,399,000 | |
| 262,952,000 | |
| 189,805,000 | |
| 183,531,000 | |
| 178,206,000 | |
| 173,760,871 | |
| 173,900,000 | |
| 222,900,000 | |
| 271,900,000 | |
| 272,750,000 | |
| 273,600,000 | |
| 277,950,000 | |
| 282,300,000 | |
| 277,600,000 | |
| 272,900,000 | |
| 267,900,000 | |
| 262,900,000 | |
| 220,200,000 | |
| 177,500,000 | |
| 173,250,000 | |
| 169,000,000 | |
| 163,750,000 | |
| 158,500,000 | |
| 151,900,000 | |
| 145,300,000 | |
| 136,350,000 | |
| 127,400,000 | |
| 85,700,000 | |
| 83,600,000 | |
| 82,050,000 | |
| 80,500,000 |